Total Payments
$13,390
2024 Payments
$1,905
Companies
33
Transactions
370
Medicare Patients
1,094
Medicare Billing
$104,452
Payment Breakdown by Category
Food & Beverage$7,518 (56.1%)
Other$4,250 (31.7%)
Travel$1,472 (11.0%)
Consulting$150.00 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,518 | 361 | 56.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,000 | 1 | 22.4% |
| Travel and Lodging | $1,472 | 3 | 11.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,250 | 4 | 9.3% |
| Consulting Fee | $150.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $4,121 | 4 | $0 (2017) |
| ABBVIE INC. | $2,178 | 117 | $0 (2024) |
| Gilead Sciences, Inc. | $1,530 | 32 | $0 (2024) |
| UCB, Inc. | $653.39 | 3 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $617.36 | 35 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $500.67 | 32 | $0 (2024) |
| Celgene Corporation | $434.76 | 30 | $0 (2024) |
| Medivators Inc. | $431.87 | 2 | $0 (2018) |
| QOL Medical, LLC | $383.75 | 15 | $0 (2024) |
| PFIZER INC. | $254.17 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,905 | 89 | ABBVIE INC. ($372.67) |
| 2023 | $1,643 | 79 | ABBVIE INC. ($425.23) |
| 2022 | $2,212 | 151 | ABBVIE INC. ($767.95) |
| 2021 | $592.32 | 31 | AbbVie Inc. ($241.28) |
| 2019 | $55.65 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($55.65) |
| 2018 | $350.00 | 1 | Medivators Inc. ($350.00) |
| 2017 | $6,632 | 18 | Valeant Pharmaceuticals North America LLC ($4,121) |
All Payment Transactions
370 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Gastroenterology | ||||||
| 12/27/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: GALLSTONES | ||||||
| 12/18/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Rare Disease | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/27/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: LIVER DISEASE | ||||||
| 11/26/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: LIVER DISEASE | ||||||
| 11/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.87 | General |
| 11/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: LIVER DISEASE | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $122.23 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $113.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: LIVER DISEASE | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $116.37 | General |
| Category: GALLSTONES | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Rare Disease | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 618 | 669 | $253,012 | $59,751 |
| 2022 | 8 | 415 | 443 | $160,300 | $38,657 |
| 2021 | 4 | 61 | 61 | $15,652 | $6,044 |
Total Patients
1,094
Total Services
1,173
Medicare Billing
$104,452
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 140 | 140 | $75,560 | $17,034 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 111 | $45,856 | $10,920 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 155 | $46,988 | $10,528 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 58 | 68 | $35,879 | $9,701 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 57 | 57 | $20,539 | $4,594 | 22.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 60 | 67 | $11,149 | $2,741 | 24.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $7,592 | $1,868 | 24.6% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 25 | 25 | $6,979 | $1,851 | 26.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 17 | 18 | $1,409 | $301.98 | 21.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $1,061 | $210.80 | 19.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 117 | 117 | $64,233 | $15,695 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 57 | $24,405 | $6,181 | 25.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 65 | 65 | $23,985 | $5,541 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 78 | $23,470 | $5,470 | 23.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 57 | 69 | $12,899 | $3,307 | 25.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 17 | $10,080 | $2,171 | 21.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 19 | $913.14 | $202.85 | 22.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 21 | 21 | $315.00 | $90.34 | 28.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $7,490 | $2,781 | 37.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 18 | $3,404 | $1,441 | 42.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $3,303 | $1,248 | 37.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $1,456 | $573.57 | 39.4% |
About Dr. Gary Matusow, DO
Dr. Gary Matusow, DO is a Specialist healthcare provider based in Egg Harbor Township, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033154463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Matusow, DO has received a total of $13,390 in payments from pharmaceutical and medical device companies, with $1,905 received in 2024. These payments were reported across 370 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($7,518).
As a Medicare-enrolled provider, Matusow has provided services to 1,094 Medicare beneficiaries, totaling 1,173 services with total Medicare billing of $104,452. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Gastroenterology
- Location Egg Harbor Township, NJ
- Active Since 06/19/2006
- Last Updated 08/21/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1033154463
Products in Payments
- XIFAXAN (Drug) $4,622
- Epclusa (Drug) $921.96
- ENTYVIO (Biological) $577.92
- ZEPOSIA (Drug) $510.22
- RINVOQ (Biological) $451.29
- LINZESS (Drug) $361.44
- Vosevi (Drug) $350.00
- SUCRAID (Drug) $340.60
- SKYRIZI (Biological) $323.55
- CREON (Drug) $254.03
- MAVYRET (Drug) $244.93
- XELJANZ (Drug) $239.68
- HUMIRA (Biological) $222.07
- DUPIXENT (Biological) $176.19
- TYSABRI (Biological) $150.00
- DIFICID (Drug) $138.93
- INJECTAFER (Drug) $137.99
- VOQUEZNA (Drug) $136.47
- MONOFERRIC (Drug) $135.59
- RELTONE 200 MG (Drug) $132.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.